Furusawa T, Cavero R, Liu Y, Li H, et al. Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer. Mol Carcinog 2024 Feb 27. doi: 10.1002/mc.23705.
PMID: 38411275